Infectious Diseases (except HIV/AIDS)

  1. Analytical performance of rapid antigen tests for the detection of SARS-CoV-2 during widespread circulation of the Omicron variant

    1. Hiromichi Suzuki
    2. Yusaku Akashi
    3. Daisuke Kato
    4. Yuto Takeuchi
    5. Yoshihiko Kiyasu
    6. Norihiko Terada
    7. Yoko Kurihara
    8. Miwa Kuwahara
    9. Shino Muramatsu
    10. Atsuo Ueda
    11. Shigeyuki Notake
    12. Koji Nakamura

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Real-world effectiveness of casirivimab and imdevimab among patients diagnosed with COVID-19 in the ambulatory setting: a retrospective cohort study using a large claims database

    1. Mohamed Hussein
    2. Wenhui Wei
    3. Vera Mastey
    4. Robert J Sanchez
    5. Degang Wang
    6. Dana J Murdock
    7. Boaz Hirshberg
    8. David M Weinreich
    9. Jessica J Jalbert

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States

    1. Katherine E. Mues
    2. Brenna Kirk
    3. Deesha A. Patel
    4. Alice Gelman
    5. L. Scott Chavers
    6. Carla A. Talarico
    7. Daina B. Esposito
    8. David Martin
    9. James Mansi
    10. Xing Chen
    11. Nicolle M. Gatto
    12. Nicolas Van de Velde

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part

    1. Hiroshi Mukae
    2. Hiroshi Yotsuyanagi
    3. Norio Ohmagari
    4. Yohei Doi
    5. Takumi Imamura
    6. Takuhiro Sonoyama
    7. Takahiro Fukuhara
    8. Genki Ichihashi
    9. Takao Sanaki
    10. Keiko Baba
    11. Yosuke Takeda
    12. Yuko Tsuge
    13. Takeki Uehara

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination

    1. Grace Kenny
    2. Riya Negi
    3. Sophie O'Reilly
    4. Alejandro Garcia-Leon
    5. Dana Alalwan
    6. Colette Marie Gaillard
    7. Gurvin Saini
    8. Rosana Inzitari
    9. Eoin R. Feeney
    10. Obada Yousif
    11. Aoife G Cotter
    12. Eoghan de Barra
    13. Corinna Sadlier
    14. Fiona Crispie
    15. Peter Doran
    16. Virginie Gautier
    17. Patrick W.G. Mallon

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial

    1. Muhammad Raza Shah
    2. Samreen Fatima
    3. Sehrosh Naz Khan
    4. Shafi Ullah
    5. Gulshan Himani
    6. Kelvin Wan
    7. Timothy Lin
    8. Johnson Y. N. Lau
    9. Qingquan Liu
    10. Dennis S. C. Lam

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Antibody Response to SARS-CoV-2 among COVID-19 Confirmed Cases and Correlates with Neutralizing Assay in a Subgroup of Patients in Delhi National Capital Region, India

    1. Puneet Misra
    2. Shashi Kant
    3. Randeep Guleria
    4. Sanjay K. Rai
    5. Abhishek Jaiswal
    6. Suprakash Mandal
    7. Guruprasad R. Medigeshi
    8. Mohammad Ahmad
    9. Anisur Rahman
    10. Meenu Sangral
    11. Kapil Yadav
    12. Mohan Bairwa
    13. Partha Haldar
    14. Parveen Kumar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. A hybrid approach to predict COVID-19 cases using neural networks and inverse problem

    1. Subhendu Paul
    2. Emmanuel Lorin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. BIRC6 modifies risk of invasive bacterial infection in Kenyan children

    1. James J Gilchrist
    2. Silvia N Kariuki
    3. James A Watson
    4. Gavin Band
    5. Sophie Uyoga
    6. Carolyne M Ndila
    7. Neema Mturi
    8. Salim Mwarumba
    9. Shebe Mohammed
    10. Moses Mosobo
    11. Kaur Alasoo
    12. Kirk A Rockett
    13. Alexander J Mentzer
    14. Dominic P Kwiatkowski
    15. Adrian VS Hill
    16. Kathryn Maitland
    17. J Anthony G Scott
    18. Thomas N Williams

    • Curated by eLife

      Evaluation Summary:

      The paper presents evidence that a genetic variant in the BIRC6 gene increases the risk of invasive bacterial infection. This paper will be of interest to researchers working in areas relating to invasive bacterial infections, malaria, sepsis, and immunogenetics. While this paper presents a hypothesis for the mechanism through which the risk variant acts, larger samples carrying the variant that increases risk, only present in African populations, are needed to further investigate potential mechanisms.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 and Reviewer #3 agreed to share their name with the authors.)

    Reviewed by eLife

    5 evaluationsAppears in 1 listLatest version Latest activity

  10. Quantifying the information in noisy epidemic curves

    1. Kris V. Parag
    2. Christl A. Donnelly
    3. Alexander E. Zarebski

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 160 of 716 Next